Pandemic publishing poses a new COVID-19 challenge

被引:174
作者
Palayew, Adam [1 ]
Norgaard, Ole [2 ]
Safreed-Harmon, Kelly [3 ]
Andersen, Tue Helms [2 ]
Rasmussen, Lauge Neimann [2 ]
Lazarus, Jeffrey V. [3 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[3] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain
关键词
D O I
10.1038/s41562-020-0911-0
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The scientific community's response to COVID-19 has resulted in a large volume of research moving through the publication pipeline at extraordinary speed, with a median time from receipt to acceptance of 6 days for journal articles. Although the nature of this emergency warrants accelerated publishing, measures are required to safeguard the integrity of scientific evidence.
引用
收藏
页码:666 / 669
页数:4
相关论文
共 13 条
[1]   A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network [J].
Altman, Douglas G. ;
Simera, Iveta .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2016, 109 (02) :67-77
[2]  
[Anonymous], 2020, MED J DRASTICALLY SP, DOI DOI 10.1101/2020.04.18.045963
[3]  
[Anonymous], NTR
[4]  
[Anonymous], NTR
[5]  
[Anonymous], PUBL
[6]  
[Anonymous], 2019 NOV COR RES COM
[7]   Accuracy in detecting inadequate research reporting by early career peer reviewers using an online CONSORT-based peer-review tool (COBPeer) versus the usual peer-review process: a cross-sectional diagnostic study [J].
Chauvin, Anthony ;
Ravaud, Philippe ;
Moher, David ;
Schriger, David ;
Hopewell, Sally ;
Shanahan, Daniel ;
Alam, Sabina ;
Baron, Gabriel ;
Regnaux, Jean-Philippe ;
Crequit, Perrine ;
Martinez, Valeria ;
Riveros, Carolina ;
Le Cleach, Laurence ;
Recchioni, Alessandro ;
Altman, Douglas G. ;
Boutron, Isabelle .
BMC MEDICINE, 2019, 17 (01)
[8]  
Chen QY, 2020, NATURE, V579, P193, DOI 10.1038/d41586-020-00694-1
[9]  
Himmelstein DS, 2016, Satoshi Village: the blog of Daniel Himmelstein
[10]  
Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]